KR890009923A - 헤테로사이클릭 화합물 - Google Patents
헤테로사이클릭 화합물 Download PDFInfo
- Publication number
- KR890009923A KR890009923A KR1019880017218A KR880017218A KR890009923A KR 890009923 A KR890009923 A KR 890009923A KR 1019880017218 A KR1019880017218 A KR 1019880017218A KR 880017218 A KR880017218 A KR 880017218A KR 890009923 A KR890009923 A KR 890009923A
- Authority
- KR
- South Korea
- Prior art keywords
- azabicyclo
- octan
- amino
- alkyl
- carbonyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/04—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (12)
- 일반식(Ⅰ)의 헤테로사이클릭 화합물 또는 약제학적 허용되는 이의 산부가염.A-X-NHCW-Y-B (Ⅰ)상기식에서 A는의 방향족 라디칼 [여기에서, 자유 원자가는 일반식(a)의 융합 환 또는 일반식(b)의 융합환에 결합된다]이고, R1은 수소, 또는 저급알킬, 저급알콕시, 하이드록시, 할로겐, 할로(저급알킬), 아미노, 니트로, 카복스, 아미도, 페닐(저급)알킬옥시(여기에서 페닐그룹은 임의로 하나 이상의 저급알킬, 저급알킬옥시 또는 할로치환체에 의해 치환될 수 있다), (저급)알킬아미노, 디(저급)알킬아미노, 디(저급)알킬아미노 및 아실아미노중에서 선택된 하나 이상의 동일하거나 상이한 치환체이고, Z1및 Z2는 CH2-CH, NR2-CH, O-CH, S-CH, CH2-N, O-N, S-N, NR2-N, CH-NR2또는 N-NR2[여기에서 R2는 수소, (저급)알킬, 또는 페닐 또는 페닐 (저급)알킬(여기에서 페닐그룹은 하나 이상의 저급알킬, 저급알킬옥시 또는 할로치환체에 의해 임의로 치환될 수 있다)]이고, Z3및 Z4는 CH=CH, O-CH2또는 N=CH이고, Z5는 N 또는 CH이고, Z6는 O, S 또는 NH이고, X는 직접결합이거나, CO이고, W는 산소 또는 황이고, Y는 NH 또는 산소이고, B는 일반식의 포화 아자사이클릭 환이고, 여기에서 n은 2,3 또는 4이고, m은 1,2 또는 3이고, p는 0,1 또는 2이고, R3은 수소, 또는 (저급)알킬이고, R4및 R5는 각각 수소 또는 저급알킬이며 단, X가 직접결합일 경우, A는 일반식(c) 또는 (d)의 그룹이고 W는 산소이며, 환(c) 또는 (d)는 -X-NHCW-Y-B 측쇄에 대해 오르토 위치에 치환체를 함유하지 않는다.
- 제1항에 있어서, X가 CO인 화합물.
- 제1항에 있어서, A가 일반식()인 화합물,상기식에서 R6내지 R9은 독립적으로 수소 또는 제1항에서 정의한 치환체 R1이다.
- 제3항에 있어서, R6은 저급알콕시이고 R7, R8및 R9가 수소이거나 R6가 저급 알킬옥시 또는 사이클로(저급)알킬(저급)알킬옥시이고 R7이 수소이고, R8이 아미노 또는 저급알킬아미노이며 R9가 할로이거나 R7및 R9가 클로로이며 R6및 R8이 수소인 화합물.
- 제1항 내지 제3항중 어느 한 항에 있어서, B가 트로판 3-일인 화합물.
- 제1항에 있어서, A가 R1이 수소, 또는 하나의 할로(저급)알킬, 저급알콕시, 저급알킬, 아미노, (저급)알킬아미노, 디(저급)알킬아미노 또는 (저급)알카노일아미노 치환체인 일반식(a) 또는 (b)의 라디칼이거나 Z5가 CH치고 R1이 수소 또는 저급알킬, 저급알콕시, 하이드록시, 할로겐, 할로(저급)알킬, 아미노, 니트로, 카복스아미노(저급)알킬아미노, 디(저급)알킬아미노 및 (저급)알카노일아미노로부터 선택되는 하나 이상의 동일하거나 상이한 치환체인 일반식(c)의 라디칼인 화합물.
- 제1항에 있어서, N-(1-아자비사이클로)[2.2.2]옥탄-3-일)-N'-(3,5-디클로로페닐)우레아 또는 약제학적으로 허용되는 이의 염인 화합물.
- 제1항에 있어서, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-메톡시벤즈아미드 또는 약제학적으로 허용되는 이의 염인 화합물.
- 제1항에 있어서, N[[[1-아자비사이클르로[2.2.2]옥탄-3-일]아미노]카보닐]-3,5-디클로로벤즈아미드, (엔도)-N-(3,5-디클로로벤조일)-O-(8-메틸-8-아자비사이클로[3.2.1]옥트-3-일)카바메이트 또는 N-(3,5-디클로로페닐)-N'-(1,2-디메틸피라졸리딘-4-일)우레아 또는 약제학적으로 허용되는 이의 염인 화합물.
- 제1항에 있어서, N-(아자비사이클로[2.2.2]옥탄-3-일-N'-(3,5-디클로로페닐)티오우레아, (엔도)-N-(3,5-디클로로페닐)-N'(8-메틸-8-아자비사이클로[3.2.1]옥탄-3-일)우레아, N-(1-아자비사이클로[2.2.2]옥탄-3-일)-N'-(3-트리플루오로메틸페닐)우레아, N-(1-아자비사이클로[2.2.2]옥탄-3-일)-N'-(4-클로로페닐)우레아, N-(아자비사이클로[2.2.2]옥탄-3-일)-N'-(1-메틸-1H-인돌-3-일)우레아, N-(아자비사이클로[2.2.2]옥탄-3-일)-N'-(2-벤조티에닐)우레아, (S)-(-)-N-(1-아자비사이클로[2.2.2]옥탄-3-일)-N'-(3,5-디클로로페닐)우레아, (R)-(+)-N-(1-아자비사이클로[2.2.2]옥탄-3-일)-N'-(3,5-디클로로페닐)우레아, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-트리플루오로메틸벤즈아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-4-메톡시벤즈아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]나프탈렌-2-카복스아미드 또는 약제학적으로 허용되는 이의 염인 화합물.
- 제1항에 있어서, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-푸란카복스아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2,6-디메틸벤즈아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-티오펜카복스아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-플루오로벤즈아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-에톡시벤즈아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-이소프로폭시벤즈아미드, 2-알릴옥시-N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]벤즈아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-피리딘카복스아미드, (엔도)-N-[[[8-메틱-8-아자비사이클로[3.2.1]옥탄-3-일]아미노]카보닐]-2-메톡시벤즈아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-메틸벤즈아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-(사이클로프로필)메톡시)벤즈아미드, (S)-N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-메톡시아미드, (R)-N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-메톡시벤즈아미드 또는 (엔도)-O-N-[[[8-메틸-8-아자비사이클로[3.2.1]옥탄-3-일]-N-(3,5디클로로포닐)카바메이트 또는 약제학적으로 허용되는 이의 연인 화합물.
- 유효량의 일반식(Ⅰ)의 화합물 또는 약제학적으로 허용되는 이의 산부가염을 편두통, 구토, 불안증, 위장병 또는 정신병 치료를 필요로 하는 온혈동물에게 투여함을 특징으로 하여 상기 질명을 치료하는 방법.A-X-NHCW-Y-B (Ⅰ)상기식에서 A는의 방향족 라디칼 [여기에서, 자유 원자가는 일반식(a)의 융합 환 또는 일반식(b)의 융합환에 결합된다]이고 R1은 수소, 또는 저급알킬, 저급알콕시, 하이드록시, 할로겐, 할로(저급)알킬, 아미노, 니트로, 카복스아미도, 페닐(저급)알킬옥시(여기에서 페닐그룹은 임의로 하나 이상의 저급알킬, 저급알킬옥시 또는 할로치환체에 의해 치환될 수 있다), (저급)알킬아미노, 디(저급)알킬아미노, 디(저급)알킬아미노 및 아실아미노중에서 선택된 하나 이상의 동일하거나 상이한 치환체이고, Z1및 Z2는 CH2-CH, NR2-CH, O-CH, S-CH, CH2-N, O-N, S-N, NR2-N, CH-NR2또는 N-NR2[여기에서 R2는 수소, (저급)알킬, 또는 페닐 또는 페닐 (저급)알킬(여기에서 페닐그룹은 하나 이상의 저급알킬, 저급알킬옥시 또는 할로치환체에 의해 임의로 치환될 수 있다)이다]이고, Z3및 Z4는 CH=CH, O-CH2또는 N=CH이고, Z5는 N 또는 CH이고, Z6는 O, S 또는 NH이고, X는 직접 결합이거나, CO이고, W는 산소 또는 황이고, Y는 NH 또는 산소이고, B는 일반식또는 이의 N-옥사이드,의 포화 아자사이클릭 환이고, 여기에서 n은 2,3 또는 4이고, m은 1,2 또는 3이고, p는 0,1 또는 2이고, R3은 수소, 또는 (저급)알킬이고, R4및 R5는 각각 수소 또는 저급알킬이며 단, X가 직접결합일 경우, A는 일반식(c) 또는 (d)의 그룹이고 W는 산소이며, 환 (c) 또는 (d)는 -X-NHCW-Y-B 측쇄에 대해 오르토 위치에 치환체를 함유하지 않는다.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878730193A GB8730193D0 (en) | 1987-12-24 | 1987-12-24 | Heterocyclic compounds |
JP8730193 | 1987-12-24 | ||
GB8730193 | 1987-12-24 | ||
GB888819728A GB8819728D0 (en) | 1988-08-19 | 1988-08-19 | Heterocyclic compounds |
GB8819728 | 1988-08-19 | ||
JP8819728 | 1988-08-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR890009923A true KR890009923A (ko) | 1989-08-04 |
KR970009588B1 KR970009588B1 (ko) | 1997-06-14 |
Family
ID=26293248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880017218A KR970009588B1 (ko) | 1987-12-24 | 1988-12-22 | 헤테로사이클릭 화합물 |
Country Status (18)
Country | Link |
---|---|
US (2) | US4983600A (ko) |
EP (2) | EP0361629B1 (ko) |
JP (1) | JP2588265B2 (ko) |
KR (1) | KR970009588B1 (ko) |
AT (2) | ATE67200T1 (ko) |
AU (1) | AU611976B2 (ko) |
CA (1) | CA1334095C (ko) |
DE (2) | DE3850255T2 (ko) |
DK (2) | DK710488A (ko) |
ES (2) | ES2053959T3 (ko) |
FI (1) | FI95031C (ko) |
GB (1) | GB2213816B (ko) |
GR (1) | GR3002701T3 (ko) |
HU (1) | HU204267B (ko) |
IE (2) | IE63474B1 (ko) |
IL (1) | IL88644A (ko) |
PH (1) | PH27437A (ko) |
PT (1) | PT89286B (ko) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK443489D0 (da) * | 1989-09-08 | 1989-09-08 | Ferrosan As | Substituerede urinstofforbindelser, deres fremstilling og anvendelse |
GB8922622D0 (en) * | 1989-10-07 | 1989-11-22 | Wyeth John & Brother Ltd | Aroylureas |
GB2236751B (en) | 1989-10-14 | 1993-04-28 | Wyeth John & Brother Ltd | Heterocyclic compounds |
DK40890D0 (da) * | 1990-02-16 | 1990-02-16 | Ferrosan As | Substituerede urinstofforbindelser, deres fremstilling og anvendelse |
DE4009565A1 (de) * | 1990-03-24 | 1991-09-26 | Merck Patent Gmbh | Indolderivate |
GB9106571D0 (en) * | 1991-03-27 | 1991-05-15 | Erba Carlo Spa | Derivatives of substituted imidazol-2-one and process for their preparation |
US5223613A (en) * | 1990-04-27 | 1993-06-29 | G. D. Searle & Co. | Azatetracycle compounds and process of preparing same |
US5140023A (en) * | 1990-04-27 | 1992-08-18 | G. D. Searle & Co. | Azatetracycle compounds |
JP3122671B2 (ja) * | 1990-05-23 | 2001-01-09 | 協和醗酵工業株式会社 | 複素環式化合物 |
ES2080482T3 (es) * | 1990-12-28 | 1996-02-01 | Kyowa Hakko Kogyo Kk | Derivado de quinoleina. |
DK0573522T3 (da) * | 1991-03-01 | 1995-03-06 | Pfizer | 1-Azabicyclo(3,2,2)nonan-3-aminderivater |
US5234921A (en) * | 1991-03-07 | 1993-08-10 | G. D. Searle & Co. | Meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof as pharmaceuticals |
JPH05507942A (ja) * | 1991-03-07 | 1993-11-11 | ジー.ディー.サール アンド カンパニー | 新規セロトニン作動性剤としての新規なmeso―アザ環式芳香族酸アミド化合物およびエステル化合物 |
US5137893A (en) * | 1991-03-07 | 1992-08-11 | G. D. Searle & Co. | Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof |
US5227377A (en) * | 1991-03-07 | 1993-07-13 | G. D. Searle & Co. | Meso-azacyclic amides of certain bicyclic carboxylic acids |
US5260303A (en) * | 1991-03-07 | 1993-11-09 | G. D. Searle & Co. | Imidazopyridines as serotonergic 5-HT3 antagonists |
US5219850A (en) * | 1991-03-07 | 1993-06-15 | G. D. Searle & Co. | Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof |
US5196547A (en) * | 1991-03-07 | 1993-03-23 | G. D. Searle & Co. | Meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof |
US5516782A (en) * | 1991-03-07 | 1996-05-14 | G. D. Searle & Co. | New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents |
GB9121835D0 (en) * | 1991-10-15 | 1991-11-27 | Smithkline Beecham Plc | Pharmaceuticals |
JPH05310732A (ja) * | 1992-03-12 | 1993-11-22 | Mitsubishi Kasei Corp | シンノリン−3−カルボン酸誘導体 |
US5190953A (en) * | 1992-03-26 | 1993-03-02 | A. H. Robins Company, Incorporated | Heterocyclic carboxylic acid amides and esters of azabicyclic compounds as gastric prokinetic, antiemetic, anxiolytic and antiarrhythmic agents |
US5244907A (en) * | 1992-03-26 | 1993-09-14 | A. H. Robins Company, Incorporated | Carbocyclic carboxylic acid amides and esters of azabicyclic compounds as gastric prokinetic, antiemetic, anxiolytic and antiarrhythmic agents |
NZ251687A (en) * | 1992-03-31 | 1995-12-21 | Glaxo Group Ltd | Oxadiazol- and thiadiazol- phenylcarbamates and -phenylureas and pharmaceutical compositions thereof |
GB9206989D0 (en) * | 1992-03-31 | 1992-05-13 | Glaxo Group Ltd | Chemical compounds |
GB2269747B (en) * | 1992-08-19 | 1996-06-05 | Wyeth John & Brother Ltd | Aroyl-ureas as pharmaceuticals, particularly 5-ht3 antagonists |
GB9217629D0 (en) * | 1992-08-19 | 1992-09-30 | Wyeth John & Brother Ltd | Aroylureas |
GB9224144D0 (en) * | 1992-11-18 | 1993-01-06 | Erba Carlo Spa | Phenyl-imidazolidinone derivatives and process for their preparation |
GB9314174D0 (en) * | 1993-07-08 | 1993-08-18 | American Home Prod | 5-ht3-antagonists |
EP0888345B1 (en) * | 1996-03-20 | 2010-05-05 | Wake Forest University Health Sciences | Sigma-2 receptors as biomarkers of tumor cell proliferation |
US6676925B1 (en) * | 1996-03-20 | 2004-01-13 | Wake Forest University | Sigma-2 receptors as biomarkers of tumor cell proliferation |
US6022884A (en) | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
CA2407520C (en) | 2000-04-27 | 2010-02-02 | Wake Forest University Health Sciences | Sigma-2 receptors as biomarkers of tumor cell proliferation |
US6492385B2 (en) | 2000-08-18 | 2002-12-10 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease |
US6486172B2 (en) | 2000-08-18 | 2002-11-26 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
WO2002016358A2 (en) | 2000-08-18 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
AU2001282875A1 (en) | 2000-08-21 | 2002-03-04 | Pharmacia And Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease |
WO2002015662A2 (en) | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists |
PE20021019A1 (es) | 2001-04-19 | 2002-11-13 | Upjohn Co | Grupos azabiciclicos sustituidos |
AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
AR036041A1 (es) * | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen |
CA2458375A1 (en) | 2001-08-24 | 2003-03-06 | Pharmacia & Upjohn Company | Substituted-heteroaryl-7-aza¬2.2.1|bicycloheptanes for the treatment of disease |
WO2003018586A1 (en) * | 2001-08-24 | 2003-03-06 | Pharmacia & Upjohn Company | Substituted-aryl 7-aza[2.2.1]bicycloheptanes for the treatment of disease |
BR0212477A (pt) * | 2001-09-12 | 2004-08-24 | Upjohn Co | 7-aza[2.2.1] bicicloheptanos substituìdos para o tratamento de doenças |
HUP0402289A2 (hu) | 2001-10-02 | 2005-02-28 | Pharmacia & Upjohn Company | Gyógyhatású azabiciklusos csoporttal helyettesített kondenzált heteroaril-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
US6849620B2 (en) | 2001-10-26 | 2005-02-01 | Pfizer Inc | N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
BR0213760A (pt) * | 2001-10-26 | 2004-10-19 | Upjohn Co | Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição |
JP2005511613A (ja) * | 2001-11-08 | 2005-04-28 | ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー | 疾患治療用アザビシクロ置換ヘテロアリール化合物 |
MXPA04004373A (es) | 2001-11-09 | 2004-08-11 | Upjohn Co | Compuestos heterociclicos condensados con fenilo azabiciclo para el tratamiento de enfermedades. |
JP2005522456A (ja) | 2002-02-15 | 2005-07-28 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | Cns関連障害治療のためのアザビシクロ置換ベンゾイルアミドおよびチオアミド |
US6858613B2 (en) * | 2002-02-19 | 2005-02-22 | Pfizer Inc. | Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease |
EP1476448A2 (en) * | 2002-02-19 | 2004-11-17 | PHARMACIA & UPJOHN COMPANY | Azabicyclic compounds for the treatment of disease |
WO2003072578A1 (en) * | 2002-02-20 | 2003-09-04 | Pharmacia & Upjohn Company | Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity |
US7176198B2 (en) * | 2002-08-01 | 2007-02-13 | Pfizer Inc. | 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
JP2006506395A (ja) * | 2002-11-01 | 2006-02-23 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | CNS疾患の治療のための、α7ニコチンアゴニスト活性及び5HT3アンタゴニスト活性を有する化合物 |
EP1736156A4 (en) * | 2004-04-15 | 2010-06-16 | Eisai R&D Man Co Ltd | COMPOSITION CONTAINING 4-AMINO-5-CHLORO-N-¬ (1R, 3R, 5S) -8-METHYL-8-AZABICYCLO-3.2.1 OCT-3-YL-2-β-methyl-2-ynyloxy BENZAMIDE STABILIZED |
JP6117708B2 (ja) | 2011-03-18 | 2017-04-19 | ジェンザイム・コーポレーション | グルコシルセラミド合成酵素阻害剤 |
MA37975B2 (fr) | 2012-09-11 | 2021-03-31 | Genzyme Corp | Inhibiteurs de synthase de glucosylcéramide |
BR112023000798A2 (pt) | 2020-07-24 | 2023-02-07 | Genzyme Corp | Composições farmacêuticas compreendendo venglustat |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4207327A (en) * | 1977-08-19 | 1980-06-10 | A. H. Robins Company, Inc. | N-(4-Pyrazolidinyl)benzamides and their amino precursors |
EP0099194A3 (en) * | 1982-07-03 | 1984-04-11 | Beecham Group Plc | Novel benzamides |
EP0158265A2 (en) * | 1984-04-13 | 1985-10-16 | Beecham Group Plc | Benzamide and anilide derivatives |
CA1260474A (en) * | 1984-12-03 | 1989-09-26 | Raymond A. Stokbroekx | Benzoxazol- and benzothiazolamine derivatives |
GB8525913D0 (en) * | 1985-10-21 | 1985-11-27 | Beecham Group Plc | Compounds |
DE3650772T2 (de) * | 1985-04-27 | 2003-04-03 | Hoffmann La Roche | Derivate von Indazole-3-carboxamide und -3-carboxylsäure |
GB8520616D0 (en) * | 1985-08-16 | 1985-09-25 | Beecham Group Plc | Compounds |
GB8525844D0 (en) * | 1985-10-19 | 1985-11-20 | Beecham Group Plc | Compounds |
EP0235878A3 (en) * | 1986-01-16 | 1989-06-14 | Beecham Group Plc | Novel compounds |
EP0255297B1 (en) * | 1986-07-31 | 1993-04-21 | Beecham Group Plc | Azabicyclic compounds, process for their preparation, and their pharmaceutical use |
-
1988
- 1988-12-08 AU AU26702/88A patent/AU611976B2/en not_active Ceased
- 1988-12-08 IE IE102988A patent/IE63474B1/en not_active IP Right Cessation
- 1988-12-08 IE IE366188A patent/IE62231B1/en not_active IP Right Cessation
- 1988-12-09 IL IL88644A patent/IL88644A/xx not_active IP Right Cessation
- 1988-12-09 CA CA000585519A patent/CA1334095C/en not_active Expired - Fee Related
- 1988-12-12 HU HU886399A patent/HU204267B/hu not_active IP Right Cessation
- 1988-12-14 EP EP89202801A patent/EP0361629B1/en not_active Expired - Lifetime
- 1988-12-14 ES ES89202801T patent/ES2053959T3/es not_active Expired - Lifetime
- 1988-12-14 DE DE3850255T patent/DE3850255T2/de not_active Expired - Fee Related
- 1988-12-14 AT AT88311802T patent/ATE67200T1/de not_active IP Right Cessation
- 1988-12-14 EP EP88311802A patent/EP0323077B1/en not_active Expired - Lifetime
- 1988-12-14 GB GB8829164A patent/GB2213816B/en not_active Expired - Fee Related
- 1988-12-14 ES ES88311802T patent/ES2051867T3/es not_active Expired - Lifetime
- 1988-12-14 AT AT89202801T patent/ATE107304T1/de not_active IP Right Cessation
- 1988-12-14 DE DE8888311802T patent/DE3864807D1/de not_active Expired - Fee Related
- 1988-12-20 DK DK710488A patent/DK710488A/da not_active Application Discontinuation
- 1988-12-21 PT PT89286A patent/PT89286B/pt not_active IP Right Cessation
- 1988-12-21 FI FI885917A patent/FI95031C/fi not_active IP Right Cessation
- 1988-12-22 KR KR1019880017218A patent/KR970009588B1/ko not_active IP Right Cessation
- 1988-12-22 JP JP63324701A patent/JP2588265B2/ja not_active Expired - Fee Related
- 1988-12-23 PH PH37977A patent/PH27437A/en unknown
-
1989
- 1989-10-16 US US07/421,920 patent/US4983600A/en not_active Expired - Lifetime
- 1989-12-19 US US07/453,000 patent/US5106843A/en not_active Expired - Lifetime
-
1991
- 1991-09-12 GR GR91401252T patent/GR3002701T3/el unknown
-
1993
- 1993-07-08 DK DK082793A patent/DK82793A/da not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR890009923A (ko) | 헤테로사이클릭 화합물 | |
KR890012649A (ko) | 아릴아미도(및 아릴티오아미도)-아자비사이클로 알칸으로 기억력을 향상시키거나 기억력 부족을 교정시키는 방법 | |
NO884202L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazolin-2-okso-1-karboksylsyrederivater. | |
SG49053A1 (en) | Arylalkylamines process for preparing them and pharmaceutical compositions containing them | |
EP0352123A3 (en) | 4-oxoquinoline-3-carboxylic acid derivatives, their preparation and their use | |
EP1310494A4 (en) | PPAR-DELTA ACTIVATORS | |
PT93066A (pt) | Processo para a preparacao de derivados heterociclicos contendo nucleos bengenicos fundidos com nucleos monoazotados substituidos e de composicoes farmaceuticas que os contem | |
DE69205327T2 (de) | Harnstoffderivate, Verfahren zu ihrer Herstellung und diese enthaltende Medikamente. | |
KR940005633A (ko) | 약제학적으로 유용한 항경련제 설파메이트의 이미데이트 유도체 | |
MY103837A (en) | Thiazolidinedione derivatives as hypoglycemic agents. | |
GB1273412A (en) | Control of pests with cycloalkane derivatives of nitrated aryl compounds | |
FI98372B (fi) | Menetelmä farmaseuttisesti käyttökelpoisten -D-fenyylitioksylosidien valmistamiseksi | |
GB1348558A (en) | Meta-bis-anilide derivatives and their use as herbicides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20011023 Year of fee payment: 5 |
|
LAPS | Lapse due to unpaid annual fee |